MULTIPLE NONMELANOMA SKIN-CANCER - EVIDENCE THAT DIFFERENT MHC GENES ARE ASSOCIATED WITH DIFFERENT CANCERS

被引:9
作者
CZARNECKI, D
TAIT, B
NICHOLSON, I
LEWIS, A
机构
[1] REPATRIAT GEN HOSP,HEIDELBERG,VIC,AUSTRALIA
[2] ROYAL MELBOURNE HOSP,TISSUE TYPING LAB,MELBOURNE,VIC,AUSTRALIA
[3] SKIN & CANC FDN FITZROY,MELBOURNE,VIC,AUSTRALIA
关键词
MULTIPLE NONMELANOMA SKIN CANCER; HLA; DR1; DR4; DR7; DR53;
D O I
10.1159/000247107
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
HLA DR frequencies of patients with multiple non-melanoma skin cancers were analysed. There were significant differences in the frequencies of HLA DR1, DR4 and DR7 between patients who only had basal cell carcinomas and patients who had both basal and squamous cell carcinomas. There were significant differences in the frequency of HLA DR53 between the two groups. This antigen is in linkage disequilibrium with HLA DR4 and DR7, and it is not possible to distinguish the primary susceptibility locus.
引用
收藏
页码:88 / 90
页数:3
相关论文
共 15 条
  • [1] AUBRY F, 1985, CANCER-AM CANCER SOC, V55, P907, DOI 10.1002/1097-0142(19850215)55:4<907::AID-CNCR2820550433>3.0.CO
  • [2] 2-5
  • [3] CARNECKI D, 1992, DERMATOLOGY, V185, P9
  • [4] CARNECKI D, 1992, INT J CANCER, V50, P874
  • [5] HLA AND MULTIPLE SKIN CARCINOMAS
    CERIMELE, D
    CONTU, L
    CARCASSI, C
    COSTA, G
    LANASA, G
    SANNA, E
    CAMPUS, GV
    [J]. DERMATOLOGICA, 1988, 176 (04): : 176 - 181
  • [6] HLA-DR1 IS NOT A SIGN OF POOR PROGNOSIS FOR THE DEVELOPMENT OF MULTIPLE BASAL-CELL CARCINOMAS
    CZARNECKI, D
    LEWIS, A
    NICHOLSON, I
    TAIT, B
    NASH, C
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 26 (05) : 717 - 719
  • [7] SQUAMOUS-CELL CARCINOMA IN SOUTHERN AND NORTHERN AUSTRALIA
    CZARNECKI, D
    COLLINS, N
    MEEHAN, C
    OBRIEN, T
    LEAHY, S
    NASH, CA
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 1992, 31 (07) : 492 - 493
  • [8] FAMILIAL OCCURRENCE OF MULTIPLE NONMELANOMA SKIN-CANCER
    CZARNECKI, D
    ZALCBERG, J
    MEEHAN, C
    OBRIEN, T
    LEAHY, S
    BANKIER, A
    NASH, CG
    [J]. CANCER GENETICS AND CYTOGENETICS, 1992, 61 (01) : 1 - 5
  • [9] CZARNECKI DB, 1991, CANCER-AM CANCER SOC, V68, P439, DOI 10.1002/1097-0142(19910715)68:2<439::AID-CNCR2820680238>3.0.CO
  • [10] 2-L